Verition Fund Management’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,620
| Closed | -$19.8K | – | 3179 |
|
|
2025
Q1 | $19.8K | Sell |
1,620
-90
| -5% | -$1.1K | ﹤0.01% | 2571 |
|
|
2024
Q4 | $33.9K | Buy |
1,710
+180
| +12% | +$3.56K | ﹤0.01% | 2478 |
|
|
2024
Q3 | $41.3K | Hold |
1,530
| – | – | ﹤0.01% | 2345 |
|
|
2024
Q2 | $57K | Sell |
1,530
-180
| -11% | -$6.71K | ﹤0.01% | 2136 |
|
|
2024
Q1 | $80.5K | Buy |
1,710
+90
| +6% | +$4.24K | ﹤0.01% | 1993 |
|
|
2023
Q4 | $71.3K | Buy |
1,620
+140
| +9% | +$6.16K | ﹤0.01% | 1719 |
|
|
2023
Q3 | $67.3K | Buy |
1,480
+80
| +6% | +$3.64K | ﹤0.01% | 1802 |
|
|
2023
Q2 | $93.8K | Sell |
1,400
-40
| -3% | -$2.68K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $61.9K | Sell |
1,440
-90
| -6% | -$3.87K | ﹤0.01% | 1771 |
|
|
2022
Q4 | $47.7K | Hold |
1,530
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q3 | $89K | Hold |
1,530
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q2 | $119K | Hold |
1,530
| – | – | ﹤0.01% | 1956 |
|
|
2022
Q1 | $162K | Sell |
1,530
-90
| -6% | -$9.53K | ﹤0.01% | 1595 |
|
|
2021
Q4 | $149K | Buy |
1,620
+135
| +9% | +$12.4K | ﹤0.01% | 1588 |
|
|
2021
Q3 | $300K | Buy |
1,485
+405
| +38% | +$81.8K | ﹤0.01% | 1220 |
|
|
2021
Q2 | $232K | Hold |
1,080
| – | – | ﹤0.01% | 1355 |
|
|
2021
Q1 | $245K | Buy |
1,080
+480
| +80% | +$109K | ﹤0.01% | 1125 |
|
|
2020
Q4 | $107K | Buy |
600
+200
| +50% | +$35.7K | ﹤0.01% | 904 |
|
|
2020
Q3 | $86K | Buy |
+400
| New | +$86K | ﹤0.01% | 912 |
|